or Try an Advanced Search...

    Biomarkers Stocks List

    Symbol Grade Name % Change
    TTOO F T2 Biosystems, Inc. -7.80
    MYGN F Myriad Genetics, Inc. -1.18
    CNTG F Centogene N.V. 0.00
    ANRO F Alto Neuroscience, Inc. -4.22
    POAI F Predictive Oncology Inc. 5.58
    LIXT F Lixte Biotechnology Holdings, Inc. 2.01
    ACON F Aclarion, Inc. 1.42
    QTRX F Quanterix Corporation 6.35
    CGEN F Compugen Ltd. 1.40
    IDYA F IDEAYA Biosciences, Inc. 4.15
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Health Information Services Medical Devices Medical Instruments & Supplies
    Related Stock Lists: Biotechnology Medicine Cancer Clinical Medicine Life Sciences Biopharmaceutical Cell Biology Chemical Pathology Diagnostic Tests Disease Drug Discovery Medical Genetics Ovarian Cancer Pharmaceutical Precision Medicine Targeted Therapy Treatment Of Cancer Whole Blood Antibodies Antibody

    Related ETFs - A few ETFs which own one or more of the above listed Biomarkers stocks.

    Symbol Grade Name Weight
    GNOM F Global X Genomics & Biotechnology ETF 2.8
    PINK D Simplify Health Care ETF 1.98
    RJMG A FT Raymond James Multicap Growth Equity ETF 1.74
    PBE D PowerShares Dynamic Biotech & Genome 1.61
    WDNA D WisdomTree BioRevolution Fund 1.02
    View all Biomarkers ETFs...
    Compare ETFs
    Compare GNOM to PINK Compare GNOM to RJMG Compare PINK to RJMG

        Biomarkers Stocks Recent News

        Date Stock Title
        Nov 21 ACON Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
        Nov 20 MYGN Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
        Nov 19 MYGN Myriad Genetics Announces Prequel® Prenatal Screening Can Now be Performed Eight Weeks into Pregnancy
        Nov 19 MYGN Myriad Genetics price target lowered to $21 from $32 at Morgan Stanley
        Nov 18 IDYA IDEAYA Biosciences Appoints Stu Dorman as Chief Commercial Officer
        Nov 15 IDYA Jim Cramer Says This Tobacco Stock Is 'Undervalued' But He's Not Recommending It
        Nov 15 POAI Predictive Oncology Third Quarter 2024 Earnings: Misses Expectations
        Nov 15 CGEN Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Health Information Services Medical Devices Medical Instruments & Supplies
        Related Stock Lists: Biotechnology Cancer Medicine Life Sciences Biopharmaceutical Cell Biology Chemical Pathology Clinical Medicine Diagnostic Tests Disease Ovarian Cancer Pharmaceutical Treatment Of Cancer Whole Blood Antibodies Antibody Antibody Therapy Artificial Intelligence Autoimmune Disease Autoimmune Disorders
        Biomarkers

        A biomarker, or biological marker is a measurable indicator of some biological state or condition. Biomarkers are often measured and evaluated to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers are used in many scientific fields.

        More about Biomarkers
        Browse All Tags